HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells - PubMed (original) (raw)
. 1991 Sep 1;147(5):1512-21.
Affiliations
- PMID: 1715361
HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells
R P Johnson et al. J Immunol. 1991.
Abstract
CTL directed at the highly conserved HIV-1 gag protein have been described in HIV-1 seropositive persons and may be an important host defense against this retrovirus. Presently only limited data are available regarding the specific epitopes recognized by these CTL. In this study, we have performed a detailed examination of the gag-specific CTL response in three HIV-1 seropositive subjects, using both unstimulated PBMC and cloned CTL. Lysis of gag-expressing targets was found to be mediated by CD3+CD8+ lymphocytes and restricted by class I Ag. Multiple class I Ag were found to restrict gag epitopes in each subject studied, with as many as three of these Ag involved in presenting gag CTL epitopes in a single subject. The majority of gag-specific CTL activity was found to be directed against epitopes in the p24 subunit of the gag protein, with at least seven different HLA class I-restricted CTL p24 epitopes identified in these three subjects. Less CTL activity was directed against p17 subunit of gag and two CTL epitopes were identified in this protein. Although as many as four different epitopes in gag were recognized using CTL from a single subject, none of the epitopes was recognized by CTL from more than one subject. Analysis of gag epitope recognition using cloned CTL demonstrated heterogeneity and specificity not appreciated using unstimulated PBMC. The identification of multiple relatively conserved epitopes in the HIV-1 gag protein and the heterogeneity of CTL responses to this protein may have important implications for vaccine development and our understanding of AIDS pathogenesis.
Similar articles
- Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific CD8+ T cells: cytotoxic T-lymphocyte epitopes and precursor frequencies.
van Baalen CA, Klein MR, Geretti AM, Keet RI, Miedema F, van Els CA, Osterhaus AD. van Baalen CA, et al. AIDS. 1993 Jun;7(6):781-6. AIDS. 1993. PMID: 7689847 - Fine-specificity of cytotoxic T lymphocytes which recognize conserved epitopes of the Gag protein of human immunodeficiency virus type 1.
van Baalen CA, Klein MR, Huisman RC, Dings ME, Kerkhof Garde SR, Geretti AM, Gruters R, van Els CA, Miedema F, Osterhaus AD. van Baalen CA, et al. J Gen Virol. 1996 Aug;77 ( Pt 8):1659-65. doi: 10.1099/0022-1317-77-8-1659. J Gen Virol. 1996. PMID: 8760412 - Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from southern Africa.
Masemola AM, Mashishi TN, Khoury G, Bredell H, Paximadis M, Mathebula T, Barkhan D, Puren A, Vardas E, Colvin M, Zijenah L, Katzenstein D, Musonda R, Allen S, Kumwenda N, Taha T, Gray G, McIntyre J, Karim SA, Sheppard HW, Gray CM; HIVNET 028 Study Team. Masemola AM, et al. J Immunol. 2004 Oct 1;173(7):4607-17. doi: 10.4049/jimmunol.173.7.4607. J Immunol. 2004. PMID: 15383595 - Identification of highly conserved and broadly cross-reactive HIV type 1 cytotoxic T lymphocyte epitopes as candidate immunogens for inclusion in Mycobacterium bovis BCG-vectored HIV vaccines.
Ferrari G, Kostyu DD, Cox J, Dawson DV, Flores J, Weinhold KJ, Osmanov S. Ferrari G, et al. AIDS Res Hum Retroviruses. 2000 Sep 20;16(14):1433-43. doi: 10.1089/08892220050140982. AIDS Res Hum Retroviruses. 2000. PMID: 11018863 Review. - Cytotoxic T lymphocytes against HIV.
Walker BD, Plata F. Walker BD, et al. AIDS. 1990 Mar;4(3):177-84. doi: 10.1097/00002030-199003000-00001. AIDS. 1990. PMID: 1693514 Review.
Cited by
- Immunological Control of HIV-1 Disease Progression by Rare Protective HLA Allele.
Zhang Y, Chikata T, Kuse N, Murakoshi H, Gatanaga H, Oka S, Takiguchi M. Zhang Y, et al. J Virol. 2022 Nov 23;96(22):e0124822. doi: 10.1128/jvi.01248-22. Epub 2022 Nov 3. J Virol. 2022. PMID: 36326273 Free PMC article. - Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonist.
Meneveau MO, Petroni GR, Salerno EP, Lynch KT, Smolkin M, Woodson E, Chianese-Bullock KA, Olson WC, Deacon D, Patterson JW, Grosh WW, Slingluff CL. Meneveau MO, et al. J Immunother Cancer. 2021 May;9(5):e002214. doi: 10.1136/jitc-2020-002214. J Immunother Cancer. 2021. PMID: 34035112 Free PMC article. Clinical Trial. - HLA class II-Restricted CD8+ T cells in HIV-1 Virus Controllers.
Nyanhete TE, Frisbee AL, Bradley T, Faison WJ, Robins E, Payne T, Freel SA, Sawant S, Weinhold KJ, Wiehe K, Haynes BF, Ferrari G, Li QJ, Moody MA, Tomaras GD. Nyanhete TE, et al. Sci Rep. 2019 Jul 15;9(1):10165. doi: 10.1038/s41598-019-46462-8. Sci Rep. 2019. PMID: 31308388 Free PMC article. - E. coli Heat-labile Enterotoxin B Subunit as a Platform for the Delivery of HIV Gag p24 Antigen.
Martin K, Nashar TO. Martin K, et al. J Clin Cell Immunol. 2013 Apr;4(2):140. doi: 10.4172/2155-9899.1000140. Epub 2013 Apr 23. J Clin Cell Immunol. 2013. PMID: 27375923 Free PMC article. - A melanoma helper peptide vaccine increases Th1 cytokine production by leukocytes in peripheral blood and immunized lymph nodes.
Dillon PM, Olson WC, Czarkowski A, Petroni GR, Smolkin M, Grosh WW, Chianese-Bullock KA, Deacon DH, Slingluff CL Jr. Dillon PM, et al. J Immunother Cancer. 2014 Jul 15;2:23. doi: 10.1186/2051-1426-2-23. eCollection 2014. J Immunother Cancer. 2014. PMID: 25126421 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials